Watch out for scars- Vascular complication due to hyaluronic acid dermal filler

Vascular complication due to fillers

Authors

  • Sabir Hasanbeyzade Hitit University Erol Olcok Training and Research Hospital

Abstract

Introduction: The frequency of cosmetic application and the possibility of complications are increasing day by day all over the world. It can be said that the most important complication that can be seen after cross-linked hyaluronic acid filler applications is vascular complications, because there may be results such as tissue loss and vision loss. Case: A fourty six year old female patient was consulted from the plastic surgery clinic with complaints of purple discoloration and pain on her forehead. In the anamnesis,it was learned that the patient's wrinkle in the frontal region was filled with filler 4 days ago. A bluish-purple area in a reticular pattern that does not disappear with pressing was observed,starting from the glabellar area and progressing towards the frontal hairline. Vascular complication due filler material and ischemia was considered in the patient and treatment was started immediately. Totally 300 U of hyaluronidase was injected intra and subdermally. It was recommended to mix  of topical betamethasone valerate and fusidic acid three times a day and apply topically to the complained area, and apply hot compress 4 times a day for 4 minutes. The patient was referred for hyperbaric oxygen therapy for an average of 2-2.5 hours per day for 2 consecutive days. On the 7th day after the first hyaluronidase administration, the patient's physical examination revealed no signs of significant ischemia and vascular occlusion. Discussion: Our aim in sharing this case was to state that although the risk of vascular complications in filler applications is related to the amount of filling, there is a risk of vascular complications even in very-very small filling applications. In addition, if there is a previous surgical, traumatic or burn scar tissue in an area, we think it would be beneficial to think twice before applying.

References

Hayreh SS, Kolder HE, Weingeist TA. Central retinal artery occlusion and retinol tolerance time. Opthalmology. 1980;87(1):75–8.

Loh KT, Chua JJ, Lee HM, et al. Prevention and management of vision loss relating to facial filler injections. Singapore Med J. 2016;57(8):438–43.

Tobalem S, Scultz JS, Chronopoulos A. Central retinal artery occlusion-Rethinking retinal survival time. BMC Ophthalmol. 2019;18(1):101.

Taylor GI, Shoukath S, Gascoigne A, et al. The functional anatomy of the opthalmic angiosome and itsimplications in blindness as a complication of cosmetic facial ller procedures. Plast Reconstr Surg. 2020;146(4):745.

Won Lee, Hyoung-Jin Moon, Ji-Soo Kim. Safe Glabellar Wrinkle Correction With Soft Tissue Filler Using Doppler Ultrasound. Aesthet Surg J. 2021;41(9):1081-9.

Beleznay K, Carruthers J, Humphrey S, et al. Update on avoiding and treating blindness from llers: A recent review of the world literature. Aesthet Surg J. 2019;39(6):662–74.

Zhou SB, Chaing, MD, Liu, K. False sense of safety: blunt cannulas cause the majority of severe vascular complications in hyaluronic acid injection. Plast Reconstr Surg. 2020;146(2):240e–1e.

Van Loghem J. Sensitivity of aspiration as a safety test before injection of soft tissue llers. J Cosmet Dermatol. 2018;17:39–46.

Torbeck RL, Schwarcz R, Hazan E, et al. In vitro evaluation of preinjection aspiration for hyaluronic fillers as a safety checkpoint. Dermatol Surg. 2019;45(7):954–8.

Kapoor KM, Kapoor P, Heydenrych I, Bertossi D. Vision loss associated with hyaluronic acid llers: a systematic review of the literature. Aesth Plast Surg. 2020;44(3): 929–44.

Gibbs M, English J, Zirwas M. Livedo reticularis: An update. J Am Acad Dermatol. 2005;(52):1009–19.

Carruthers JD, Fagien S, Rohrich RJ, Weinkle S, Carruthers A. Blindness caused by cosmetic filler injection: a review of cause and therapy. Plast Reconstr Surg. 2014;134:1197-201.

Schelke LW, Velthuis P, Kadouch J, Swift A. Early ultrasound for diagnosis and treatment of vascular adverse events with hyaluronic acid llers. J Am Acad Dermatol. 2019;S0190– 9622(19)32392–8.

Mir AI, Ali N, Kohli A et al. Role of the antiplatelet drug in deep vein thrombosis. J Med Sci Clin Res. 2017;5(10):28689–95.

Hwang CJ, Morgan PV, Pimentel A, et al. Rethinking the role of nitroglycerin ointment in ischemic vascular ller complications: An animal model with ICG imaging. Ophthalmic Plast Reconstr Surg. 2016;32(2):118–22.

Al-Quattan MM, Al-Kattan WM. Skin wound healing, ischemia-reperfusion injury, and nerve rejeneration: Similarities in the sequential events and molecular basis. Can J Plast Surg. 2004;12(3):131–3.

Downloads

Published

2023-07-02

How to Cite

1.
Sabir Hasanbeyzade. Watch out for scars- Vascular complication due to hyaluronic acid dermal filler: Vascular complication due to fillers. J Pak Assoc Dermatol [Internet]. 2023Jul.2 [cited 2025Dec.14];33(2):748-53. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/2143

Issue

Section

Case Reports